Tonix Pharmaceuticals Holding Corp. (TNXP) Earnings History
Annual and quarterly earnings data from 2008 to 2024
Loading earnings history...
TNXP EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
TNXP Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 23.1% | -1354.3% | -1288.3% |
| 2023 | 39.0% | -1523.9% | -1501.8% |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export TNXP earnings history in CSV or JSON format
Free sign-in required to download data
Tonix Pharmaceuticals Holding Corp. (TNXP) Earnings Overview
As of May 8, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) reported trailing twelve-month net income of -$99M, reflecting +97.2% year-over-year growth. The company earned $-11.12 per diluted share over the past four quarters, with a net profit margin of -1288.3%.
Looking at the long-term picture, TNXP's historical earnings data spans multiple years. The company achieved its highest annual net income of -$9,450 in fiscal 2012.
Tonix Pharmaceuticals Holding Corp. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including AXSM (-$188M net income, -28.7% margin), INVA ($504M net income, 63.8% margin), SUPN (-$29M net income, -5.4% margin), TNXP has room to improve margins relative to the peer group. Compare TNXP vs AXSM →
TNXP Earnings vs Peers
Earnings metrics vs comparable public companies
TNXP Historical Earnings Data (2008–2024)
17 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$130M | -11.5% | -$137M | $-176.60 | -1288.3% | -1354.3% |
| 2023 | -$117M | -5.8% | -$118M | $-6368.84 | -1501.8% | -1523.9% |
| 2022 | -$110M | -19.4% | -$112M | $-811.68 | - | - |
| 2021 | -$92M | -82.9% | -$92M | $-163968.00 | - | - |
| 2020 | -$50M | -76.3% | -$51M | $-5056.00 | - | - |
| 2019 | -$29M | +2.5% | -$29M | $-3866.00 | - | - |
| 2018 | -$29M | -39.0% | -$26M | $-18064.62 | - | - |
| 2017 | -$21M | +45.6% | -$21M | $-54023.02 | - | - |
| 2016 | -$39M | +19.2% | -$39M | $-199189.74 | - | - |
| 2015 | -$48M | -74.0% | -$48M | $-511212.77 | - | - |
See TNXP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TNXP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TNXP vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTNXP — Frequently Asked Questions
Quick answers to the most common questions about buying TNXP stock.
Is TNXP growing earnings?
TNXP EPS is $-11.12, with earnings growth accelerating to +97.2%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-99M.
What are TNXP's profit margins?
Tonix Pharmaceuticals Holding Corp. net margin is -1288.3%, with operating margin at -1354.3%. Below-average margins reflect competitive or cost pressures.
How consistent are TNXP's earnings?
TNXP earnings data spans 2008-2024. The accelerating earnings trend is +97.2% YoY. Historical data enables comparison across business cycles.